1. GPCR/G Protein Neuronal Signaling
  2. 5-HT Receptor
  3. S 15931

S 15931 is a 5-HT1A receptor inhibitor. S 15931 inhibits the late-phase hindpaw licking response induced by formalin and the abdominal writhing response induced by acetic acid in Mus musculus. S 15931 abolishes the spontaneous tail-flick response induced by 8-OH-DPAT in Rattus norvegicus and potentiates the analgesic effect of morphine. S 15931 is applicable for pain-related research.

For research use only. We do not sell to patients.

S 15931

S 15931 Chemical Structure

CAS No. : 153607-45-5

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

S 15931 is a 5-HT1A receptor inhibitor. S 15931 inhibits the late-phase hindpaw licking response induced by formalin and the abdominal writhing response induced by acetic acid in Mus musculus. S 15931 abolishes the spontaneous tail-flick response induced by 8-OH-DPAT in Rattus norvegicus and potentiates the analgesic effect of morphine. S 15931 is applicable for pain-related research[1].

In Vivo

S 15931 (40 mg/kg; s.c.; single administration; 30 min before testing) exerts stronger inhibitory efficacy on the late phase than the early phase of formalin-induced licking response in male NMRI mice[1].
S 15931 (40 mg/kg; s.c.; single administration; 30 min before testing) inhibits acetic acid-induced writhing response in male NMRI mice[1].
S 15931 (40 mg/kg; s.c.; single administration; 30 min before testing) induces rotarod ataxia in male NMRI mice[1].
S 15931 (40 mg/kg; s.c.; single administration; administered 20 minutes prior to 8-OH-DPAT treatment) potently inhibits the spontaneous tail-flick response induced by 8-OH-DPAT (HY-112061) in male Wistar rats[1].
S 15931 (0-10.0 mg/kg; s.c.; single administration; 60 min before testing) does not alter vocalization threshold on its own, but it enhances the analgesic effect of morphine in a dose-dependent manner in the electrically stimulated tail vocalization test in male Wistar rats, with a significant effect observed at doses ≥0.63 mg/kg[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: NMRI (male, 20-25 g, formalin-induced hindpaw licking model)[1]
Dosage: 40.0 mg/kg
Administration: s.c.; single dose; 30 minutes pre-test
Result: Achieved an ID50 of 1.2 mg/kg for inhibition of the early phase of formalin-induced licking, producing a 95% maximum observed effect at 40.0 mg/kg.
Achieved an ID50 of 0.3 mg/kg for inhibition of the late phase of formalin-induced licking, producing a 99% maximum observed effect at 40.0 mg/kg.
Animal Model: NMRI (male, 20-25 g, acetic acid-induced abdominal writhing model)[1]
Dosage: 40.0 mg/kg
Administration: s.c.; single dose; 30 minutes pre-test
Result: Achieved an ID50 of 10.4 mg/kg for inhibition of acetic acid-induced writhing, producing a 93% maximum observed effect at 40.0 mg/kg.
Animal Model: NMRI (male, 20-25 g, rotarod ataxia model)[1]
Dosage: 40.0 mg/kg
Administration: s.c.; single dose; 30 minutes pre-test
Result: Achieved an ID50 of 21.3 mg/kg for induction of rotarod ataxia, producing a 90% maximum observed effect at 40.0 mg/kg.
Animal Model: Wistar (male, 200-250 g, 8-OH-DPAT-induced spontaneous tail-flicks model)[1]
Dosage: 40.0 mg/kg
Administration: s.c.; single dose; 20 minutes pre-8-OH-DPAT
Result: Achieved an ID50 of 0.7 mg/kg for inhibition of 8-OH-DPAT-induced spontaneous tail-flicks, producing a 99% maximum observed effect at 40.0 mg/kg.
Animal Model: Wistar (male, 200-250 g, electrical tail stimulation vocalization model)[1]
Dosage: 0.01, 0.04, 0.16, 0.83, 2.5, 10.0 mg/kg
Administration: s.c.; single dose; 60 minutes pre-test
Result: Did not significantly alter vocalization threshold relative to vehicle when administered alone.
Dose-dependently facilitated morphine's antinociceptive action, with significant potentiation observed at doses of 0.63 mg/kg, 2.5 mg/kg, and 10.0 mg/kg when co-administered with morphine.
Molecular Weight

364.48

Formula

C23H28N2O2

CAS No.
SMILES

C12=CC=CC(N3CCN(CCC4C5=C(CC4)C=CC=C5)CC3)=C1OCCO2

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
S 15931
Cat. No.:
HY-182584
Quantity:
MCE Japan Authorized Agent: